Aurinia Pharmaceuticals I...

NASDAQ: AUPH · Real-Time Price · USD
12.27
0.18 (1.49%)
At close: Aug 15, 2025, 3:59 PM
12.44
1.43%
After-hours: Aug 15, 2025, 07:44 PM EDT

Aurinia Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
5.75M -78.02M -108.18M -180.97M
Depreciation & Amortization
6.71M 11.65M 2.71M 2.76M
Stock-Based Compensation
31.6M 45.31M 32.3M 31.24M
Other Working Capital
16.57M 7.47M -371K -4.65M
Other Non-Cash Items
n/a -6.79M 462K 10.9M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
5.45M -5.61M -6.82M -21.63M
Operating Cash Flow
44.39M -33.46M -79.53M -157.69M
Capital Expenditures
-281K -718K -292K -1.5M
Cash Acquisitions
n/a n/a n/a -1.2M
Purchase of Investments
-545.83M -523.5M -523.99M -438.96M
Sales Maturities Of Investments
585.42M 529.38M 464.32M 354.43M
Other Investing Acitivies
-43K -11.86M -663K -16.63M
Investing Cash Flow
39.26M -6.71M -60.63M -103.87M
Debt Repayment
-11.99M -10.03M n/a n/a
Common Stock Repurchased
-40.24M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
3.14M 4.89M 2.43M 24.37M
Financial Cash Flow
-49.09M -5.13M 2.43M 221.11M
Net Cash Flow
34.56M -45.3M -137.73M -40.45M
Free Cash Flow
44.11M -34.18M -79.82M -159.19M